Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Basilea Pharmaceutica Ag (BPMUF)

Basilea Pharmaceutica Ag (BPMUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Basilea Pharmaceutica Ag Hegenheimermattweg 167b Allschwil V8 4123 CHE

www.basilea.com P: 41-61-606-1111

Description:

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company developing products that address the medical challenge of increasing resistance and non-response to current treatment options in the therapeutic areas of bacterial infections, fungal infections and cancer. With two commercialized drugs, the company is committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions.

Key Statistics

Overview:

Market Capitalization, $K 526,777
Enterprise Value, $K 472,337
Shares Outstanding, K 11,851
Annual Sales, $ 175,590 K
Annual Net Income, $ 11,640 K
EBIT, $ 0 K
EBITDA, $ 23,150 K
60-Month Beta 0.65
% of Institutional Shareholders 0.00%
Float, K 11,851
% Float 100.00%

Growth:

1-Year Return 15.16%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 29.57%
5-Year Earnings Growth 132.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/14/24 [--]
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BPMUF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 18.33
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 6.63%
Debt/Equity -1.54
Price/Sales N/A
Price/Cash Flow 39.34
Price/Book N/A
Book Value/Share -0.94
Interest Coverage -1.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar